Yih Lee

1.5k total citations
17 papers, 1.1k citations indexed

About

Yih Lee is a scholar working on Oncology, Psychiatry and Mental health and Surgery. According to data from OpenAlex, Yih Lee has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Psychiatry and Mental health and 3 papers in Surgery. Recurrent topics in Yih Lee's work include Bacteriophages and microbial interactions (3 papers), Migraine and Headache Studies (3 papers) and Nausea and vomiting management (2 papers). Yih Lee is often cited by papers focused on Bacteriophages and microbial interactions (3 papers), Migraine and Headache Studies (3 papers) and Nausea and vomiting management (2 papers). Yih Lee collaborates with scholars based in United States, United Kingdom and Australia. Yih Lee's co-authors include John Yin, Tim Wyant, Jing Xu, Julie Lekstrom-Himes, Debra D. Donaldson, Michael H. Davidson, Mingxiu Hu, Clarissa E. Vergunst, Paul P. Tak and Timothy Wyant and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and The American Journal of Cardiology.

In The Last Decade

Yih Lee

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yih Lee United States 13 369 368 231 162 135 17 1.1k
Koji Nishimura Japan 21 199 0.5× 565 1.5× 159 0.7× 89 0.5× 151 1.1× 84 1.5k
Steven Yu United States 14 170 0.5× 680 1.8× 182 0.8× 340 2.1× 82 0.6× 30 1.1k
Warren Heston United States 12 270 0.7× 344 0.9× 181 0.8× 240 1.5× 64 0.5× 15 1.1k
Kazuhiro Shigemoto Japan 24 165 0.4× 861 2.3× 234 1.0× 130 0.8× 58 0.4× 65 1.7k
Ashish Rajput Canada 21 471 1.3× 1.1k 2.9× 269 1.2× 123 0.8× 127 0.9× 36 2.2k
Daniel J. Kim United States 15 153 0.4× 748 2.0× 128 0.6× 238 1.5× 100 0.7× 18 1.4k
Charles Vinson United States 20 215 0.6× 1.1k 3.0× 342 1.5× 171 1.1× 91 0.7× 29 1.8k
Anne‐Marie Bernard France 11 456 1.2× 892 2.4× 591 2.6× 292 1.8× 165 1.2× 21 1.8k
Alexandra King United States 14 270 0.7× 612 1.7× 123 0.5× 148 0.9× 84 0.6× 16 1.1k
Kohgaku Eguchi Japan 20 118 0.3× 440 1.2× 122 0.5× 207 1.3× 104 0.8× 33 973

Countries citing papers authored by Yih Lee

Since Specialization
Citations

This map shows the geographic impact of Yih Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yih Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yih Lee more than expected).

Fields of papers citing papers by Yih Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yih Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yih Lee. The network helps show where Yih Lee may publish in the future.

Co-authorship network of co-authors of Yih Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yih Lee. A scholar is included among the top collaborators of Yih Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yih Lee. Yih Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lekstrom-Himes, Julie, Debra D. Donaldson, Yih Lee, et al.. (2011). Effect of CC Chemokine Receptor 2 CCR2 Blockade on Serum C-Reactive Protein in Individuals at Atherosclerotic Risk and With a Single Nucleotide Polymorphism of the Monocyte Chemoattractant Protein-1 Promoter Region. The American Journal of Cardiology. 107(6). 906–911. 144 indexed citations
2.
Dees, Elizabeth Claire, Jeffrey R. Infante, Roger B. Cohen, et al.. (2010). Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 67(4). 945–954. 64 indexed citations
3.
Macarulla, Teresa, Andrés Cervantes, Élena Elez, et al.. (2010). Phase I Study of the Selective Aurora A Kinase Inhibitor MLN8054 in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Pharmacodynamics. Molecular Cancer Therapeutics. 9(10). 2844–2852. 73 indexed citations
4.
Vergunst, Clarissa E., Daniëlle M. Gerlag, Lars Klareskog, et al.. (2008). Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial. Arthritis & Rheumatism. 58(7). 1931–1939. 178 indexed citations
5.
Galsky, Matthew D., Mario Eisenberger, William K. Kelly, et al.. (2008). Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. 26(13). 2147–2154. 115 indexed citations
6.
Lee, Yih, Anup Majumdar, Kevin J. Petty, et al.. (2004). Evaluation of Potential Inductive Effects of Aprepitant on Cytochrome P450 3A4 and 2C9 Activity. The Journal of Clinical Pharmacology. 44(3). 215–223. 88 indexed citations
7.
Kramer, Mark S., Andrew Winokur, Jeffrey E. Kelsey, et al.. (2003). Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression. Neuropsychopharmacology. 29(2). 385–392. 219 indexed citations
8.
Feuring, Martin, Yih Lee, N. Michiels, et al.. (2003). Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects. The Journal of Clinical Pharmacology. 43(8). 912–917. 29 indexed citations
9.
Goldberg, Michael R., David Sciberras, Marina De Smet, et al.. (2001). Influence of β‐adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5‐HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol. British Journal of Clinical Pharmacology. 52(1). 69–76. 37 indexed citations
10.
Britten, Carolyn D., Eric K. Rowinsky, Steven L. Soignet, et al.. (2001). A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies.. PubMed. 7(12). 3894–903. 65 indexed citations
11.
Goldberg, Michael R., Yih Lee, Kamlesh P. Vyas, et al.. (2000). Rizatriptan, a Novel 5‐HT1B/1D Agonist for Migraine: Single‐ and Multiple‐Dose Tolerability and Pharmacokinetics in Healthy Subjects. The Journal of Clinical Pharmacology. 40(1). 74–83. 9 indexed citations
12.
Lee, Yih, Andrew Sterrett, Michael R. Goldberg, et al.. (1998). Pharmacokinetics and tolerability of intravenous rizatriptan in healthy females. Biopharmaceutics & Drug Disposition. 19(9). 577–581. 7 indexed citations
13.
Lee, Yih, et al.. (1997). Antiserum inhibition of propagating viruses. Biotechnology and Bioengineering. 55(3). 542–546. 4 indexed citations
14.
Lee, Yih & John Yin. (1996). Detection of evolving viruses. Nature Biotechnology. 14(4). 491–493. 36 indexed citations
15.
Lee, Yih, et al.. (1995). Characterization of endothelial cell locomotion using a Markov chain model. Biochemistry and Cell Biology. 73(7-8). 461–472. 17 indexed citations
16.
Lee, Yih, et al.. (1995). Extremo-phage: In vitro selection of tolerance to a hostile environment. Journal of Molecular Evolution. 41(2). 9 indexed citations
17.
Lee, Yih. (1972). Top Necrosis and Cellular Changes in Soybean Doubly Infected by Soybean Mosaic and Bean Pod Mottle Viruses. Phytopathology. 62(8). 839–839. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026